Why do cancers have high aerobic glycolysis?
The DOI matches its Crossref record; 95 of the 96 references it cites were found in a registry or an index.
Abstract
If carcinogenesis occurs by somatic evolution, then common components of the cancer phenotype result from active selection and must, therefore, confer a significant growth advantage. A near-universal property of primary and metastatic cancers is upregulation of glycolysis, resulting in increased glucose consumption, which can be observed with clinical tumour imaging. We propose that persistent metabolism of glucose to lactate even in aerobic conditions is an adaptation to intermittent hypoxia in pre-malignant lesions. However, upregulation of glycolysis leads to microenvironmental acidosis requiring evolution to phenotypes resistant to acid-induced cell toxicity. Subsequent cell populations with upregulated glycolysis and acid resistance have a powerful growth advantage, which promotes unconstrained proliferation and invasion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300 · cited 1×
“At this penumbral layer, microenvironmental selection forces will favour phenotypes that adapt to harsh environments (through resistance to hypoxia and acid-induced cell toxicity) and successfully compete for scarce resources, such as oxygen and glucos”
BackgroundThe Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
Molecular imaging of cancer with positron emission tomography
Gambhir, S. S. (2002) · Nature Reviews Cancer · doi:10.1038/nrc882 · Cited by 1,656
Helmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Krogh, A. (1919) · The Journal of Physiology · doi:10.1113/jphysiol.1919.sp001839 · Cited by 1,426
Hypoxia-inducible factor 1: master regulator of O2 homeostasis
Semenza, G. L. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80016-6 · Cited by 1,092
Research works printed but not linked: 2
- Warburg, O. Ueber den stoffwechsel der tumoren. (Constable, London, 1930).
- Robey, I., Lien, A., Welsh, S., Baggett, B. & Gillies, R. J. HIF-1α and the glycolytic phenotype in tumors. Neoplasia (in the press).
Cited by
Items 201–300 of 392
pH control mechanisms of tumor survival and growth
Parks, S. K., Chiche, J., & Pouyssegur, J. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22400 · Cited by 357
Near-infrared (NIR) fluorescence-emitting small organic molecules for cancer imaging and therapy
Li, H., Kim, Y., Jung, H., Hyun, J. Y., & Shin, I. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00722c · Cited by 356
Liu, X., Chen, Y., Li, H., Huang, N., Jin, Q., Ren, K., & Ji, J. (2013) · ACS Nano · doi:10.1021/nn402201w · Cited by 356
Tumor metabolism: cancer cells give and take lactate
Semenza, G. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci37373 · Cited by 351
Phenylboronic Acid-Installed Polymeric Micelles for Targeting Sialylated Epitopes in Solid Tumors
Deshayes, S., Cabral, H., Ishii, T., Miura, Y., Kobayashi, S., Yamashita, T., Matsumoto, A., Miyahara, Y., Nishiyama, N., & Kataoka, K. (2013) · Journal of the American Chemical Society · doi:10.1021/ja406406h · Cited by 348
Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment
Chen, B., Dai, W., He, B., Zhang, H., Wang, X., Wang, Y., & Zhang, Q. (2017) · Theranostics · doi:10.7150/thno.16684 · Cited by 342
Metabolism of [U‐ 13 C]glucose in human brain tumors in vivo
Maher, E. A., Marin‐Valencia, I., Bachoo, R. M., Mashimo, T., Raisanen, J., Hatanpaa, K. J., Jindal, A., Jeffrey, F. M., Choi, C., Madden, C., et al. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2794 · Cited by 341
Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer
Gatenby, R. A., Smallbone, K., Maini, P. K., Rose, F., Averill, J., Nagle, R. B., Worrall, L., & Gillies, R. J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603922 · Cited by 340
Self-citationCancer‐generated lactic acid: a regulatory, immunosuppressive metabolite?
Choi, S. Y. C., Collins, C. C., Gout, P. W., & Wang, Y. (2013) · The Journal of Pathology · doi:10.1002/path.4218 · Cited by 338
Mechanoresponsive metabolism in cancer cell migration and metastasis
Zanotelli, M. R., Zhang, J., & Reinhart-King, C. A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.002 · Cited by 338
Natural D ‐glucose as a biodegradable MRI contrast agent for detecting cancer
Chan, K. W. Y., McMahon, M. T., Kato, Y., Liu, G., Bulte, J. W. M., Bhujwalla, Z. M., Artemov, D., & van Zijl, P. C. M. (2012) · Magnetic Resonance in Medicine · doi:10.1002/mrm.24520 · Cited by 337
Cellular Stress Responses in Radiotherapy
Kim, W., Lee, S., Seo, D., Kim, D., Kim, K., Kim, E., Kang, J., Seong, K. M., Youn, H., & Youn, B. (2019) · Cells · doi:10.3390/cells8091105 · Cited by 337
Zoppi, V., Hughes, S. J., Maniaci, C., Testa, A., Gmaschitz, T., Wieshofer, C., Koegl, M., Riching, K. M., Daniels, D. L., Spallarossa, A., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01413 · Cited by 336
Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L
Papandreou, I., Lim, A. L., Laderoute, K., & Denko, N. C. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.84 · Cited by 334
Park, J.-S., Kim, I.-K., Han, S., Park, I., Kim, C., Bae, J., Oh, S. J., Lee, S., Kim, J. H., Woo, D.-C., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.018 · Cited by 327
“microenvironment is not only hypoxic and acidic but also is surrounded by high interstitial pressure, which acts as a pathologic barrier to drug delivery into tumors (Gatenby and Gillies, 2004; Hockel and Vaupel, 2001; Jain, 2005).”
BackgroundHyperglycemia as a Risk Factor for Cancer Progression
Ryu, T. Y., Park, J., & Scherer, P. E. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.5.330 · Cited by 331
Review of aerobic glycolysis and its key enzymes – new targets for lung cancer therapy
Li, X., Gu, J., & Zhou, Q. (2015) · Thoracic Cancer · doi:10.1111/1759-7714.12148 · Cited by 331
Short Overview of ROS as Cell Function Regulators and Their Implications in Therapy Concepts
Milkovic, L., Cipak Gasparovic, A., Cindric, M., Mouthuy, P.-A., & Zarkovic, N. (2019) · Cells · doi:10.3390/cells8080793 · Cited by 330
Fogal, V., Richardson, A. D., Karmali, P. P., Scheffler, I. E., Smith, J. W., & Ruoslahti, E. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01101-09 · Cited by 329
pH ‐Sensitive stimulus‐responsive nanocarriers for targeted delivery of therapeutic agents
Karimi, M., Eslami, M., Sahandi‐Zangabad, P., Mirab, F., Farajisafiloo, N., Shafaei, Z., Ghosh, D., Bozorgomid, M., Dashkhaneh, F., & Hamblin, M. R. (2016) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1389 · Cited by 327
“(b) Reprinted with permission from Ref.(63) Copyright 2004 Nature) Advanced Review wires.”
BackgroundReactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment
Chen, X., Song, M., Zhang, B., & Zhang, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1580967 · Cited by 326
“ROS reduce T cell immune responses via inhibiting recognition betweenT cell receptor (TCR) andMHC-peptide complex, while adding ROS inhibitors such as catalase into theMDSCs/T cells coculture system could impair suppressive effects of MDSCs on T cell proliferation [28].”
BackgroundInfluentialInhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease
Fraisl, P., Aragonés, J., & Carmeliet, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2761 · Cited by 326
“With regard to targeting PHDs, caution is warranted, as induction of the HIF1α programme by inhibiting PHDs in tumour cells may counteract a normalization effect on endothelial cells, in part by enhancing the release of angiogenic signals, and fuelling tumour metabolism, growth and metastasi”
BackgroundMetabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship
Netea-Maier, R. T., Smit, J. W. A., & Netea, M. G. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.10.037 · Cited by 326
Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects
Chen, A.-N., Luo, Y., Yang, Y.-H., Fu, J.-T., Geng, X.-M., Shi, J.-P., & Yang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688910 · Cited by 324
Metabolic origins of spatial organization in the tumor microenvironment
Carmona-Fontaine, C., Deforet, M., Akkari, L., Thompson, C. B., Joyce, J. A., & Xavier, J. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700600114 · Cited by 323
Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c‐Jun activation
Mendler, A. N., Hu, B., Prinz, P. U., Kreutz, M., Gottfried, E., & Noessner, E. (2012) · International Journal of Cancer · doi:10.1002/ijc.26410 · Cited by 319
Catabolic efficiency of aerobic glycolysis: The Warburg effect revisited
Vazquez, A., Liu, J., Zhou, Y., & Oltvai, Z. N. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-58 · Cited by 319
The Warburg effect and its cancer therapeutic implications
Chen, Z., Lu, W., Garcia-Prieto, C., & Huang, P. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9086-x · Cited by 318
Gasparre, G., Porcelli, A. M., Bonora, E., Pennisi, L. F., Toller, M., Iommarini, L., Ghelli, A., Moretti, M., Betts, C. M., Martinelli, G. N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703056104 · Cited by 316
Review: Synovial Cell Metabolism and Chronic Inflammation in Rheumatoid Arthritis
Falconer, J., Murphy, A. N., Young, S. P., Clark, A. R., Tiziani, S., Guma, M., & Buckley, C. D. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40504 · Cited by 315
Administration, distribution, metabolism and elimination of polymer therapeutics
Markovsky, E., Baabur-Cohen, H., Eldar-Boock, A., Omer, L., Tiram, G., Ferber, S., Ofek, P., Polyak, D., Scomparin, A., & Satchi-Fainaro, R. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.021 · Cited by 313
Critical Role of Glucose Metabolism in Rheumatoid Arthritis Fibroblast‐like Synoviocytes
Garcia‐Carbonell, R., Divakaruni, A. S., Lodi, A., Vicente‐Suarez, I., Saha, A., Cheroutre, H., Boss, G. R., Tiziani, S., Murphy, A. N., & Guma, M. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39608 · Cited by 310
Koo, S., Park, O. K., Kim, J., Han, S. I., Yoo, T. Y., Lee, N., Kim, Y. G., Kim, H., Lim, C., Bae, J.-S., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c09171 · Cited by 307
Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs
Jorth, P., Staudinger, B. J., Wu, X., Hisert, K. B., Hayden, H., Garudathri, J., Harding, C. L., Radey, M. C., Rezayat, A., Bautista, G., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.07.006 · Cited by 306
Bensaad, K., & Vousden, K. H. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.04.004 · Cited by 305
Biodistribution Mechanisms of Therapeutic Monoclonal Antibodies in Health and Disease
Tabrizi, M., Bornstein, G. G., & Suria, H. (2010) · The AAPS Journal · doi:10.1208/s12248-009-9157-5 · Cited by 305
Glycolysis in cancer: A potential target for therapy
Gatenby, R. A., & Gillies, R. J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.021 · Cited by 304
Self-citationDe Milito, A., Iessi, E., Logozzi, M., Lozupone, F., Spada, M., Marino, M. L., Federici, C., Perdicchio, M., Matarrese, P., Lugini, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4095 · Cited by 301
Mitochondrial gateways to cancer
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Rigoni, A., Vacchelli, E., Michaud, M., Zischka, H., Castedo, M., & Kroemer, G. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.08.002 · Cited by 300
Biology of glucose metabolization in cancer cells
Fadaka, A., Ajiboye, B., Ojo, O., Adewale, O., Olayide, I., & Emuowhochere, R. (2017) · Journal of Oncological Sciences · doi:10.1016/j.jons.2017.06.002 · Cited by 300
The Warburg Effect 97 Years after Its Discovery
Pascale, R. M., Calvisi, D. F., Simile, M. M., Feo, C. F., & Feo, F. (2020) · Cancers · doi:10.3390/cancers12102819 · Cited by 300
Hypoxia signalling controls metabolic demand
Brahimi-Horn, M. C., Chiche, J., & Pouysségur, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.003 · Cited by 298
“The immediate consequence is up-regulation of the glycolytic cascade for transformation of glucose to pyruvate, together with a switch in pyruvate metabolism from transformation through the tricarboxylic acid (TCA) cycle and oxidative phosphorylation in mitochondria to conversion to lactic acid in the cytoplasm [5].”
BackgroundThe tumor microenvironment and metastatic disease
Lunt, S. J., Chaudary, N., & Hill, R. P. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9182-2 · Cited by 298
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
Kelderman, S., Heemskerk, B., van Tinteren, H., van den Brom, R. R. H., Hospers, G. A. P., van den Eertwegh, A. J. M., Kapiteijn, E. W., de Groot, J. W. B., Soetekouw, P., Jansen, R. L., et al. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-014-1528-9 · Cited by 298
The Warburg effect and drug resistance
Bhattacharya, B., Mohd Omar, M. F., & Soong, R. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13422 · Cited by 298
Swietach, P., Patiar, S., Supuran, C. T., Harris, A. L., & Vaughan-Jones, R. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.006478 · Cited by 297
Kiebish, M. A., Han, X., Cheng, H., Chuang, J. H., & Seyfried, T. N. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800319-jlr200 · Cited by 293
Shi, L., Pan, H., Liu, Z., Xie, J., & Han, W. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.44 · Cited by 292
F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer
Hong, J., Guo, F., Lu, S.-Y., Shen, C., Ma, D., Zhang, X., Xie, Y., Yan, T., Yu, T., Sun, T., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-322780 · Cited by 290
A Review of Applications of Metabolomics in Cancer
Beger, R. (2013) · Metabolites · doi:10.3390/metabo3030552 · Cited by 288
Gallagher, S. M., Castorino, J. J., Wang, D., & Philp, N. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3184 · Cited by 288
Min, K. H., Kim, J.-H., Bae, S. M., Shin, H., Kim, M. S., Park, S., Lee, H., Park, R.-W., Kim, I.-S., Kim, K., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.024 · Cited by 287
Mitochondria and Cancer: Warburg Addressed
WALLACE, D. C. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.035 · Cited by 285
Tumor-Secreted Lactic Acid Promotes IL-23/IL-17 Proinflammatory Pathway
Shime, H., Yabu, M., Akazawa, T., Kodama, K., Matsumoto, M., Seya, T., & Inoue, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7175 · Cited by 285
Causes, consequences, and therapy of tumors acidosis
Pillai, S. R., Damaghi, M., Marunaka, Y., Spugnini, E. P., Fais, S., & Gillies, R. J. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09792-7 · Cited by 282
Self-citationMetabolic genes in cancer: Their roles in tumor progression and clinical implications
Furuta, E., Okuda, H., Kobayashi, A., & Watabe, K. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.005 · Cited by 282
Guan, J.-L., Simon, A. K., Prescott, M., Menendez, J. A., Liu, F., Wang, F., Wang, C., Wolvetang, E., Vazquez-Martin, A., & Zhang, J. (2013) · Autophagy · doi:10.4161/auto.24132 · Cited by 281
HIF-1 mediates the Warburg effect in clear cell renal carcinoma
Semenza, G. L. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9081-2 · Cited by 281
Carbonic Anhydrases: Role in pH Control and Cancer
Mboge, M., Mahon, B., McKenna, R., & Frost, S. (2018) · Metabolites · doi:10.3390/metabo8010019 · Cited by 281
Surface design of magnetic nanoparticles for stimuli-responsive cancer imaging and therapy
Kang, T., Li, F., Baik, S., Shao, W., Ling, D., & Hyeon, T. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.013 · Cited by 280
Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression
Fang, J. S., Gillies, R. D., & Gatenby, R. A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.011 · Cited by 277
Self-citationLactate Activates HIF-1 in Oxidative but Not in Warburg-Phenotype Human Tumor Cells
De Saedeleer, C. J., Copetti, T., Porporato, P. E., Verrax, J., Feron, O., & Sonveaux, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046571 · Cited by 277
Tamada, M., Nagano, O., Tateyama, S., Ohmura, M., Yae, T., Ishimoto, T., Sugihara, E., Onishi, N., Yamamoto, T., Yanagawa, H., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3024 · Cited by 275
Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose
Rodrigues, T. B., Serrao, E. M., Kennedy, B. W. C., Hu, D.-E., Kettunen, M. I., & Brindle, K. M. (2014) · Nature Medicine · doi:10.1038/nm.3416 · Cited by 274
The chemistry and biology of vanadium compounds in cancer therapeutics
Kioseoglou, E., Petanidis, S., Gabriel, C., & Salifoglou, A. (2015) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2015.03.010 · Cited by 272
Multispectral Optoacoustic Tomography (MSOT) of Human Breast Cancer
Diot, G., Metz, S., Noske, A., Liapis, E., Schroeder, B., Ovsepian, S. V., Meier, R., Rummeny, E., & Ntziachristos, V. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3200 · Cited by 270
Targeted drug delivery for cancer therapy: the other side of antibodies
Firer, M. A., & Gellerman, G. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-70 · Cited by 269
The Metabolic Basis of Pulmonary Arterial Hypertension
Sutendra, G., & Michelakis, E. D. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.004 · Cited by 268
Galavotti, S., Bartesaghi, S., Faccenda, D., Shaked-Rabi, M., Sanzone, S., McEvoy, A., Dinsdale, D., Condorelli, F., Brandner, S., Campanella, M., et al. (2013) · Oncogene · doi:10.1038/onc.2012.111 · Cited by 266
Tumor Acidity, Chemoresistance and Proton Pump Inhibitors
De Milito, A., & Fais, S. (2005) · Future Oncology · doi:10.2217/14796694.1.6.779 · Cited by 265
Hashim, A. I., Zhang, X., Wojtkowiak, J. W., Martinez, G. V., & Gillies, R. J. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1644 · Cited by 265
Self-citationZhou, J., Zhang, S., Chen, Z., He, Z., Xu, Y., & Li, Z. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2127-7 · Cited by 265
Cancer‐related fatigue: Implications for breast cancer survivors
Berger, A. M., Gerber, L. H., & Mayer, D. K. (2012) · Cancer · doi:10.1002/cncr.27475 · Cited by 264
Jiao, L., Zhang, H.-L., Li, D.-D., Yang, K.-L., Tang, J., Li, X., Ji, J., Yu, Y., Wu, R.-Y., Ravichandran, S., et al. (2018) · Autophagy · doi:10.1080/15548627.2017.1381804 · Cited by 264
Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors
Miao, L., Lin, C. M., & Huang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.017 · Cited by 264
Targeting Vacuolar H+-ATPases as a New Strategy against Cancer
Fais, S., De Milito, A., You, H., & Qin, W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1805 · Cited by 264
Brown-fat-mediated tumour suppression by cold-altered global metabolism
Seki, T., Yang, Y., Sun, X., Lim, S., Xie, S., Guo, Z., Xiong, W., Kuroda, M., Sakaue, H., Hosaka, K., et al. (2022) · Nature · doi:10.1038/s41586-022-05030-3 · Cited by 263
Mitochondria-Targeted Drugs Synergize with 2-Deoxyglucose to Trigger Breast Cancer Cell Death
Cheng, G., Zielonka, J., Dranka, B. P., McAllister, D., Mackinnon, A. C., Joseph, J., & Kalyanaraman, B. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3928 · Cited by 263
TGF-β signaling in the tumor metabolic microenvironment and targeted therapies
Shi, X., Yang, J., Deng, S., Xu, H., Wu, D., Zeng, Q., Wang, S., Hu, T., Wu, F., & Zhou, H. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01349-6 · Cited by 262
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
Sutendra, G., & Michelakis, E. D. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00038 · Cited by 262
Targeting adaptive glioblastoma: an overview of proliferation and invasion
Xie, Q., Mittal, S., & Berens, M. E. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou147 · Cited by 262
Mierke, C. T. (2019) · Reports on Progress in Physics · doi:10.1088/1361-6633/ab1628 · Cited by 262
Langbein, S., Zerilli, M., zur Hausen, A., Staiger, W., Rensch-Boschert, K., Lukan, N., Popa, J., Ternullo, M. P., Steidler, A., Weiss, C., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602962 · Cited by 261
Liao, M., Yao, D., Wu, L., Luo, C., Wang, Z., Zhang, J., & Liu, B. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.12.003 · Cited by 261
Hypoxia, glucose metabolism and the Warburg’s effect
Bartrons, R., & Caro, J. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9080-3 · Cited by 260
PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth
Montal, E. D., Dewi, R., Bhalla, K., Ou, L., Hwang, B. J., Ropell, A. E., Gordon, C., Liu, W.-J., DeBerardinis, R. J., Sudderth, J., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.025 · Cited by 259
Evolutionary biology of cancer
Crespi, B., & Summers, K. (2005) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2005.07.007 · Cited by 259
Li, B., Gu, Z., Kurniawan, N., Chen, W., & Xu, Z. P. (2017) · Advanced Materials · doi:10.1002/adma.201700373 · Cited by 258
Kumagai, S., Togashi, Y., Sakai, C., Kawazoe, A., Kawazu, M., Ueno, T., Sato, E., Kuwata, T., Kinoshita, T., Yamamoto, M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.016 · Cited by 257
Funes, J. M., Quintero, M., Henderson, S., Martinez, D., Qureshi, U., Westwood, C., Clements, M. O., Bourboulia, D., Pedley, R. B., Moncada, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700690104 · Cited by 256
Emerging roles of aerobic glycolysis in breast cancer
Wu, Z., Wu, J., Zhao, Q., Fu, S., & Jin, J. (2020) · Clinical and Translational Oncology · doi:10.1007/s12094-019-02187-8 · Cited by 255
Borst, P. (2020) · IUBMB Life · doi:10.1002/iub.2367 · Cited by 252
Shlomi, T., Benyamini, T., Gottlieb, E., Sharan, R., & Ruppin, E. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002018 · Cited by 244
Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives
Seker-Polat, F., Pinarbasi Degirmenci, N., Solaroglu, I., & Bagci-Onder, T. (2022) · Cancers · doi:10.3390/cancers14020443 · Cited by 253
Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets
Miranda-Gonçalves, V., Honavar, M., Pinheiro, C., Martinho, O., Pires, M. M., Pinheiro, C., Cordeiro, M., Bebiano, G., Costa, P., Palmeirim, I., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos298 · Cited by 252
Causes and consequences of DNA hypomethylation in human cancer
Hoffmann, M. J., & Schulz, W. A. (2005) · Biochemistry and Cell Biology · doi:10.1139/o05-036 · Cited by 252
Franovic, A., Gunaratnam, L., Smith, K., Robert, I., Patten, D., & Lee, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702387104 · Cited by 250
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer
Alam, H., Tang, M., Maitituoheti, M., Dhar, S. S., Kumar, M., Han, C. Y., Ambati, C. R., Amin, S. B., Gu, B., Chen, T.-Y., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.005 · Cited by 243
“Increased aerobic glycolysis, known as the Warburg effect, is a major characteristic of cancer cells, providing them with a proliferation advantage by producing ATP as well as glucosederived metabolites for biosynthesis of nucleotides, lipids, and proteins (Gatenby and Gillies, 2004).”
BackgroundChemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
Tang, Z., Liu, Y., He, M., & Bu, W. (2019) · Angewandte Chemie · doi:10.1002/ange.201805664 · Cited by 240
McIntyre, A., Patiar, S., Wigfield, S., Li, J.-L., Ledaki, I., Turley, H., Leek, R., Snell, C., Gatter, K., Sly, W. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1877 · Cited by 239
Metadata
- Authors
- Gatenby, R. A., & Gillies, R. J.
- Affiliations
- University of Arizona (US)
- Corresponding author
- Gatenby, Robert A.
- Venue
- Nature reviews. Cancer
- Published
- 2004-11-01
- Volume
- 4
- Issue
- 11
- Pages
- 891-899
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2130503287
- Cited by
- 4,784
- References
- 96
- Citations by year
- 2026: 117 · 2025: 162 · 2024: 180 · 2023: 244 · 2022: 283 · 2021: 290 · 2020: 291 · 2019: 283 · 2018: 272 · 2017: 324 · 2016: 279 · 2015: 305 · 2014: 303 · 2013: 236 · 2012: 212
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- aerobic glycolysis, Warburg effect, cancer metabolism, somatic evolution, carcinogenesis, intermittent hypoxia, precancerous lesions, acid resistance, glucose utilization, lactic acid production, metastasis, tumor invasion
- MeSH terms
- Acidosis, Cell Transformation, Neoplastic, Glycolysis, Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Oxygen, Phenotype, Up-Regulation, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.